Alphabet Inc`s Verily said on Friday it is pausing research on glucose-sensing lens, one of its earliest projects.
The search engine giant`s life sciences division started the project in 2014 with Alcon, Novartis` eye-care division, to better manage diabetes by putting sensors on a contact lens to measure glucose levels for people with the disease.
"Our clinical work on the glucose-sensing lens demonstrated that there was insufficient consistency in our measurements of the correlation between tear glucose and blood glucose concentrations to support the requirements of a medical device," Verily said https://blog.verily.com/2018/11/update-on-our-smart-lens-program-with.html.
(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Mcap of four of top 10 most-valued firms rises by Rs 65,671 crore
India's space economy set to reach USD 40 billion by 2040: Union Minister Jitendra Singh 
Germany's economy shrank, and it's facing a spending crisis that's spreading more gloom